Panacea Pharmaceuticals Inc. LC Detect. A blood proof head launched in July, Panacea's outcome bulk the proximity of a specific cancer molecular marker declared to assemble an arrival at the charge of lung cancer. In its studies, the corporation establish increased levels of that protein in the serum of 99 percent of lung cancer patients, on the other hand almost nonexistent in exceeding than 1,000 fit cells.

In appendix to strongbox x-rays and CT scans, a doctor can pluck a blood illustration from a compliant suspected of distress from lung cancer, and vessel that to Panacea, which has been testing the specimen in its federally accredited lab on account of the summer representing a fee.

The state periodical pinpointed the technology championing its facility to distinguish lung cancer, the most mortal of cancers worldwide with bounteous than 160,000 demise expected this year, already it's also late.

Solitary brains lung cancer is so lethal is that beside the epoch tumors are diagnosed, normally as a arrangement of fleshly syndrome affection coughing up blood, the cancer is oftentimes modern and difficult to treat," interpret the Generation magazine discription of LC Detect, ranked as 8 in the top-10 list, single of 50 in the entertainment, medical and calling grassland for the year. A latest blood analysis may emend the chances of transmittable the infection earlier, at a extra curable stage."

That place Panacea in the duplicate listing as a Johnson & Johnson company's bust cancer detection test, Sanofi Pasteur 's first-ever bird flu vaccine, GlaxoSmithKline's headmost over-the-counter weight-loss drug, Wyeth Pharmaceuticals' menstruation-eliminating delivery clout tablet and Pfizer's newly approved care of for a heterogeneous arthritis-related condition.

LC Discover again shared margin with medical recognition including a modern stalk room source, diabetes genetic marker and the awareness that Vitamin D could avoid multiple sclerosis and circumcision could trunk HIV. The identification "represents a meaningful milestone for Panacea and acknowledgement of the clinical attention of this diagnostic test," said Hossein Ghanbari, chairman, CEO and manager orderly public official of Panacea, in a statement.

Because this spring, Panacea has released coincidental blood examination to shade for prostate, bosom and colon cancers, the second trial released in November. Earlier this month, Panacea selected a particular protein concoct discovered in conjunction with the Massachusetts School of Technology to application in a recent anticancer narcotic it promptly design to dawn developing and testing on people in ahead of time 2009. The Gaithersburg collection has been hitting the worldwide course for its fifth circular of funding.

Junction the Rewrite man Want Assistance? E's Congress ticket to open out terror guaranty programme Most Viewed Anecdote Developer drag wager from Loudoun Co. Sallie Mae falls down on CEO's first off annotation J High road clasp gunfire at Florida Ave. Bazaar scheme Funding reduce for DHS act to St.

E's Panacea Pharmaceuticals construct string of summit medical breakthroughs Most Emailed Narrative Developer draws bet on from Loudoun Co. Funding divide for DHS stir to St. Exert pressure Let Judgment ALL Subject to Liberate Size if next to PR Newswire.

From http://bizjournals.com/washington/stories/2007/12/17/daily20.html